🔎 Trials Near Me

Home › Amyloidosis › Florida › Miami

Amyloidosis clinical trials in Miami, FL

3 studies for Amyloidosis are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

RecruitingPhase 3
  • Clinical Trial Site, Miami
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

RecruitingPhase 3
  • University of Miami, Miami
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

RecruitingPhase 1/2
  • Sylvester Comprehensive Cancer Center - University of Miami /ID# 255856, Miami
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06158854

About Amyloidosis

Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.

More about Amyloidosis on MedlinePlus

Amyloidosis trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.